These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35730756)

  • 41. Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
    de Dreuille B; Cazals-Hatem D; Ronot M; Theou-Anton N; Dermine S; Le Beyec-Le Bihan J; Billiauws L; Le Gall M; Bado A; Joly F
    Am J Clin Nutr; 2023 Jun; 117(6):1143-1151. PubMed ID: 37270288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
    Chiba M; Masumoto K; Kaji T; Matsuura T; Morii M; Fagbemi A; Hill S; Pakarinen MP; Protheroe S; Urs A; Chen ST; Sakui S; Udagawa E; Wada M
    J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):339-346. PubMed ID: 37364133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility.
    Raphael BP; Nurko S; Jiang H; Hart K; Kamin DS; Jaksic T; Duggan C
    J Pediatr Gastroenterol Nutr; 2011 May; 52(5):590-4. PubMed ID: 21502831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure.
    Martin A; Boehm V; Zappa M; Billiauws L; Bonvalet F; Nuzzo A; Vilgrain V; Joly F; Ronot M
    Am J Clin Nutr; 2021 May; 113(5):1343-1350. PubMed ID: 33675349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
    Walter E; Dawoud C; Hütterer E; Stift A; Harpain F
    Am J Clin Nutr; 2024 May; 119(5):1187-1199. PubMed ID: 38431119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teduglutide for pediatric short bowel syndrome patients.
    Rosete BE; Wendel D; Horslen SP
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):727-733. PubMed ID: 33798402
    [No Abstract]   [Full Text] [Related]  

  • 47. Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.
    Borioli V; Cereda E; Lobascio F; Mengoli C; Caraccia M; Pagani A; Aronico N; Pedrazzoli P; Di Sabatino A; Caccialanza R
    Nutrition; 2020 May; 73():110720. PubMed ID: 32088500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variation of plasma citrulline as a predictive factor for weaning off long-term parenteral nutrition in children with neonatal short bowel syndrome.
    Proli F; Faragalli A; Talbotec C; Bucci A; Zemrani B; Chardot C; Abi Nader E; Goulet O; Lambe C
    Clin Nutr; 2021 Aug; 40(8):4941-4947. PubMed ID: 34358840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short bowel syndrome: highlights of patient management, quality of life, and survival.
    Kelly DG; Tappenden KA; Winkler MF
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):427-37. PubMed ID: 24247092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes of various pediatric short bowel syndrome in China.
    Zhang T; Feng H; Cao Y; Tao Y; Lu L; Yan W; Li F; Wang Y; Cai W
    Pediatr Surg Int; 2021 Apr; 37(4):495-502. PubMed ID: 33394086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension.
    Nakamura S; Wada M; Mizushima T; Sugita A; Tazuke Y; Ohge H; Udagawa E; Suzuki RK; Yoon M; Grimm A; Chen ST; Ikeuchi H
    Surg Today; 2023 Mar; 53(3):347-359. PubMed ID: 36201060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real-world etiologies and treatments of pediatric short bowel syndrome in Japan.
    Tazuke Y; Udagawa E; Mizushima T; Nakamura S; Fernandez J; Okuyama H
    Pediatr Int; 2022 Jan; 64(1):e15258. PubMed ID: 36163637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Teduglutide: a guide to its use in short bowel syndrome.
    McKeage K
    Clin Drug Investig; 2015 May; 35(5):335-40. PubMed ID: 25859983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study.
    Daoud DC; Schwenger KJP; Jung H; Lou W; Armstrong D; Raman M; McHattie JD; Duerksen DR; Whittaker S; Bielawska B; Jurewitsch B; Gramlich L; Allard JP
    JPEN J Parenter Enteral Nutr; 2023 Sep; 47(7):878-887. PubMed ID: 37416984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Teduglutide-Stimulated Intestinal Adaptation Is Complemented and Synergistically Enhanced by Partial Enteral Nutrition in a Neonatal Piglet Model of Short Bowel Syndrome.
    Naberhuis JK; Deutsch AS; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):853-865. PubMed ID: 26304601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucagon-like peptide 2 analogues in the treatment of intestinal failure: A qualitative exploration of the views of patients and their families in decision making.
    Sowerbutts AM; Burden S; Griffiths J; Abraham A; Farrer K; Leahy G; Teubner A; Cloutier A; Twist K; Kelly S; Lal S
    Clin Nutr ESPEN; 2021 Aug; 44():263-269. PubMed ID: 34330477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Is there life after teduglutide?].
    Martínez Martínez AL; Calles Romero LA; Etxeberría Martín E; Monasterio Jiménez O; Zabalegui Eguinoa A; Paja Fano M; Monzón Mendiolea A; Cadenas González A; Cabriada Nuno JL; Iglesias Hernández NC
    Nutr Hosp; 2020 Jul; 34(3):631-635. PubMed ID: 32406744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.
    Blüthner E; Pape UF; Tacke F; Greif S
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.